Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Ra Capital Nexus Fund, L.p.
Over the trailing 90 days, Ra Capital Nexus Fund, L.p. (Director at Artiva Biotherapeutics, Inc.) bought $170.2M of stock across 6 companies, per 32 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 32 transactions · CIK 1780117
- Net activity
- +$170.2M ($170.2M bought · $0 sold)
By Company (Trailing 90 Days)
Transactions (32)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-31 | ARTV | Buy | 24.9K | $248K | Open market or private purchase |
| 2026-07-29 | ARTV | Buy | 20.8K | $208K | Open market or private purchase |
| 2026-07-24 | ARTV | Buy | 41.3K | $413K | Open market or private purchase |
| 2026-07-23 | ARTV | Buy | 59.9K | $596K | Open market or private purchase |
| 2026-07-22 | ARTV | Buy | 84.1K | $835K | Open market or private purchase |
| 2026-07-21 | ARTV | Buy | 120.6K | $1.2M | Open market or private purchase |
| 2026-07-20 | FRNM | Buy | 4.9M | $49.2M | Grant, award or other acquisition |
| 2026-07-20 | FRNM | Buy | 367.4K | $0 | Grant, award or other acquisition |
| 2026-07-20 | FRNM | Buy | 337.0K | $3.4M | Grant, award or other acquisition |
| 2026-07-20 | FRNM | Buy | 908.1K | $0 | Grant, award or other acquisition |
| 2026-07-20 | FRNM | Buy | 553.7K | $0 | Grant, award or other acquisition |
| 2026-07-20 | FRNM | Buy | 971.0K | $0 | Grant, award or other acquisition |
| 2026-07-20 | FRNM | Buy | 6.6M | $0 | Grant, award or other acquisition |
| 2026-07-17 | ARTV | Buy | 7.9K | $71K | Open market or private purchase |
| 2026-07-16 | ARTV | Buy | 152.5K | $1.4M | Open market or private purchase |
| 2026-07-13 | ARTV | Buy | 6.6K | $59K | Open market or private purchase |
| 2026-07-10 | ARTV | Buy | 15.1K | $135K | Open market or private purchase |
| 2026-06-29 | CLYM | Buy | 70.3K | $0 | Grant, award or other acquisition |
| 2026-06-26 | ARTV | Buy | 1.9K | $17K | Open market or private purchase |
| 2026-06-25 | ARTV | Buy | 31.0K | $275K | Open market or private purchase |
| 2026-06-17 | SION | Buy | 17.3K | $0 | Grant, award or other acquisition |
| 2026-06-16 | ARTV | Buy | 124.9K | $1.1M | Open market or private purchase |
| 2026-06-15 | ARTV | Buy | 15.4K | $139K | Open market or private purchase |
| 2026-06-12 | ARTV | Buy | 391.0K | $3.4M | Open market or private purchase |
| 2026-06-11 | ARTV | Buy | 548.6K | $4.3M | Open market or private purchase |
| 2026-06-10 | ARTV | Buy | 103 | $721 | Open market or private purchase |
| 2026-06-10 | NKTX | Buy | 37.0K | $0 | Grant, award or other acquisition |
| 2026-06-09 | ARTV | Buy | 479.0K | $3.3M | Open market or private purchase |
| 2026-06-05 | CLYM | Buy | 40.0K | $0 | Grant, award or other acquisition |
| 2026-05-28 | TYRA | Buy | 13.2K | $0 | Grant, award or other acquisition |
| 2026-05-11 | ARTV | Buy | 6.5M | $75.0M | Open market or private purchase |
| 2026-05-11 | ARTV | Buy | 2.2M | $25.0M | Open market or private purchase |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Ra's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.